ATE460425T1 - Histondeacetylaseinhibitor und verfahren zu dessen herstellung - Google Patents

Histondeacetylaseinhibitor und verfahren zu dessen herstellung

Info

Publication number
ATE460425T1
ATE460425T1 AT04746393T AT04746393T ATE460425T1 AT E460425 T1 ATE460425 T1 AT E460425T1 AT 04746393 T AT04746393 T AT 04746393T AT 04746393 T AT04746393 T AT 04746393T AT E460425 T1 ATE460425 T1 AT E460425T1
Authority
AT
Austria
Prior art keywords
compounds
production
histone deacetylase
deacetylase inhibitor
present
Prior art date
Application number
AT04746393T
Other languages
English (en)
Inventor
Minoru Yoshida
Norikazu Nishino
Original Assignee
Riken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riken filed Critical Riken
Application granted granted Critical
Publication of ATE460425T1 publication Critical patent/ATE460425T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/126—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT04746393T 2003-06-20 2004-06-18 Histondeacetylaseinhibitor und verfahren zu dessen herstellung ATE460425T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003177298 2003-06-20
PCT/JP2004/008924 WO2004113366A1 (ja) 2003-06-20 2004-06-18 ヒストン脱アセチル化酵素阻害剤およびその製造方法

Publications (1)

Publication Number Publication Date
ATE460425T1 true ATE460425T1 (de) 2010-03-15

Family

ID=33534930

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04746393T ATE460425T1 (de) 2003-06-20 2004-06-18 Histondeacetylaseinhibitor und verfahren zu dessen herstellung

Country Status (6)

Country Link
US (1) US7662778B2 (de)
EP (1) EP1640380B1 (de)
JP (1) JP4550738B2 (de)
AT (1) ATE460425T1 (de)
DE (1) DE602004025935D1 (de)
WO (1) WO2004113366A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070754A1 (fr) * 2002-02-20 2003-08-28 Minoru Yoshida Inhibiteurs d'histone desacetylase et procede de production de ces inhibiteurs
US7250514B1 (en) 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
JP2007262058A (ja) * 2006-03-03 2007-10-11 Tokyo Univ Of Science 糸状菌の分化抑制剤
WO2008029565A1 (en) 2006-09-05 2008-03-13 Kyushu Institute Of Technology Compound having inhibitory activity on histone deacetylase, and pharmaceutical comprising the compound as active ingredient
US8129418B2 (en) * 2007-09-09 2012-03-06 University Of Florida Research Foundation Macrocyclic compounds and methods of treatment
US8293513B2 (en) * 2007-12-14 2012-10-23 Georgetown University Histone deacetylase inhibitors
US20110123644A1 (en) * 2008-04-11 2011-05-26 University Of Florida Research Foundation Macrocyclic compounds and methods of treatment
WO2014205445A1 (en) * 2013-06-21 2014-12-24 Dana-Farber Cancer Institute, Inc. Oncogene associated with human cancers and methods of use thereof
CN109912686B (zh) * 2019-03-13 2022-07-05 北京大学深圳研究生院 一种靶向hdac的稳定多肽类抑制剂及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922837A (en) * 1995-09-20 1999-07-13 Merck & Co., Inc. Antiprotozoal cyclic tetrapeptides
KR20010023449A (ko) * 1997-09-02 2001-03-26 나가시마 카쭈시게, 노미야마 아키히코 신규한 환상 테트라펩티드 유도체 및 그 의약 용도
JPH11130795A (ja) * 1997-10-29 1999-05-18 Yamanouchi Pharmaceut Co Ltd Ｙｍ−１７５２０１物質
TR200101049T2 (tr) 1998-10-13 2002-01-21 Fujisawa Pharmaceutical Co. Ltd. Siklik tetrapeptid bileşiği ve kullanımı
JP4269041B2 (ja) * 1999-03-02 2009-05-27 国立大学法人九州工業大学 新規な環状テトラペプチド誘導体とその医薬用途
US20030078369A1 (en) * 1999-07-23 2003-04-24 Meinke Peter T. Apicidin-derived cyclic tetrapeptides
AU6109600A (en) 1999-07-23 2001-02-13 Merck & Co., Inc. Apicidin-derived cyclic tetrapeptides
CA2317003A1 (en) 2000-02-28 2001-08-28 Hidenori Nakajima Gene expression potentiator
JP2001316283A (ja) 2000-02-28 2001-11-13 Yasushi Kaneda 遺伝子発現増強剤
JP2005517683A (ja) 2001-12-28 2005-06-16 藤沢薬品工業株式会社 環状テトラペプチド化合物およびその用途
WO2003070754A1 (fr) 2002-02-20 2003-08-28 Minoru Yoshida Inhibiteurs d'histone desacetylase et procede de production de ces inhibiteurs

Also Published As

Publication number Publication date
EP1640380A4 (de) 2006-08-23
DE602004025935D1 (de) 2010-04-22
US7662778B2 (en) 2010-02-16
EP1640380B1 (de) 2010-03-10
JPWO2004113366A1 (ja) 2007-09-20
EP1640380A1 (de) 2006-03-29
WO2004113366A1 (ja) 2004-12-29
US20070185071A1 (en) 2007-08-09
JP4550738B2 (ja) 2010-09-22

Similar Documents

Publication Publication Date Title
EA200500342A1 (ru) Гетероциклические замещённые пиперазины для лечения шизофрении
NO20070606L (no) Inhibitorer av IAP
DE602006016313D1 (de) Biphenylderivate und ihre verwendung bei der behandlung von hepatitis c
NO20050741L (no) Ny fremgangsmate for syntesen og ny krystallinsk form av agomelatin og farmasoytiske sammensetninger inneholdende den
IS7925A (is) Hýdroxýetýlamínafleiður til að meðhöndla Alzheimers-sjúkdóm
DK1480961T3 (da) Glutaminylbaserede DPIV-inhibitorer
ATE443043T1 (de) Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
ATE368031T1 (de) Neue gamma secretase inhibitoren
ATE536349T1 (de) In der 2-stellung durch phenyl substituierte 1h- benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
CY1111327T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος
ATE461923T1 (de) Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren
CY1109740T1 (el) Νεα μεθοδος συνθεσης παραγωγων της 1,3,4,5 -τετραϋδρο-2η- 3-βενζαζεπιν-2-ονης και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων προσθηκης της σε ενα φαρμακευτικως αποδεκτο οξυ
DE602004011255D1 (de) Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit
ATE440833T1 (de) Antithrombotische diamide
UY27825A1 (es) Derivados de n-acilamino bencil eter
WO2006063113A3 (en) Ureas as factor xa inhibitors
CY1109975T1 (el) Παρα-αλκυλ-υποκατεστημενα αμιδια ν-(4-υδροξυ-3-μεθοξυ-βενζυλο) κιναμμωμικου οξεος και η χρησιμοποιηση τους για την παρασκευη φαρμακων
ATE432930T1 (de) Benzosulfonamide derivate, deren verfahren zum herstellung, und deren verwendung zur behandlung von schmerzen
DE602004006118D1 (de) 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER
DE602004025935D1 (de) Histondeacetylaseinhibitor und verfahren zu dessen herstellung
DE60329326D1 (de) Tace inhibitoren
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
WO2006055434A3 (en) Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease
ATE543803T1 (de) 3-ä2-(3-azylamino-2-oxo-2h-pyridin-1- yl)acetylaminoü-4-oxopentansäurederivate und deren verwendung als caspase-inhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties